A Conceptual Framework for a Novel Therapeutic Protocol: NanoStem Airway Restoration Protocol (NSARP) for Repairing, Restoring, Cleaning, and Revitalizing Airways in Chronic Obstructive Pulmonary Disease and Related Lung Disorders

This conceptual paper proposes the NanoStem Airway Restoration Protocol (NSARP), an innovative, multifaceted therapeutic paradigm integrating mesenchymal stem cell (MSC) therapy, nanotechnology-enabled precision drug delivery systems, and glycocalyx-protective agents such as dimethyl sulfoxide (DMSO) to systematically repair, restore, clean, and revitalize airways in chronic obstructive pulmonary disease (COPD) and analogous pulmonary disorders characterized by structural airway aberrations and perturbed internal lung microenvironments. The framework is rigorously grounded in multiscale mathematical modeling, encompassing advanced derivations of fluid dynamics equations for branched airway networks, oscillatory flow regimes, and nanoparticle transport; reproducible Python-based simulations of pulmonary airflow, particle deposition, and tissue regeneration dynamics; comprehensive global sensitivity analyses via Sobol indices; quantitative statistical methodologies including multilevel regression; hierarchical Bayesian inference for probabilistic treatment efficacy estimation; uncertainty quantification through Monte Carlo propagation; and explicit falsifiability criteria via testable predictions on airflow restoration, inflammatory biomarker modulation, and glycocalyx integrity metrics. The protocol leverages empirically validated physiological parameters from peer-reviewed literature, with all computational elements engineered for replicability, verifiability, and extensibility. High-fidelity TikZ visualizations illustrate airway morphologies, velocity profiles, deposition patterns, and probabilistic outputs, precisely congruent with analytical derivations and simulation results, thereby establishing a paradigm-shifting foundation for regenerative pulmonology.